Risk and survival of second primary malignancies following diagnosis of gastric mucosa-associated lymphoid tissue lymphomas: A population-based study

Peng, 2015, Primary lymphomas in the gastrointestinal tract, J Dig Dis, 16, 169, 10.1111/1751-2980.12234 Violeta, 2018, MALT lymphoma: epidemiology, clinical diagnosis and treatment, J Med Life, 11, 187, 10.25122/jml-2018-0035 Raderer, 2016, Clinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma), CA: Cancer J, 66, 153 Stathis, 2010, Treatment of gastric marginal zone lymphoma of MALT type, Expert Opin Pharmacother, 11, 2141, 10.1517/14656566.2010.497141 Turcotte, 2017, Temporal trends in treatment and subsequent neoplasm risk among 5-year survivors of childhood cancer, 1970-2015, Jama, 317, 814, 10.1001/jama.2017.0693 Tajika, 2014, Risk of second malignancies in patients with gastric marginal zone lymphomas of mucosa associate lymphoid tissue (MALT), J Gastroenterol, 49, 843, 10.1007/s00535-013-0844-8 Amiot, 2017, Second primary malignancies in patients treated for gastric mucosa-associated lymphoid tissue lymphoma, Leuk lymphoma, 58, 1, 10.1080/10428194.2017.1283033 Oka, 2012, Concurrent gastric MALT and hodgkin lymphoma: a case report, Int J Surg Pathol, 20, 201, 10.1177/1066896911417242 Capelle, 2008, Gastric MALT lymphoma: epidemiology and high adenocarcinoma risk in a nation-wide study, Eur JCancer, 44, 2470, 10.1016/j.ejca.2008.07.005 Luppi, 1996, Additional neoplasms and HCV infection in low-grade lymphoma of MALT type, Br J Haematol, 94, 373, 10.1046/j.1365-2141.1996.d01-1791.x Copie-Bergman, 2005, Metachronous gastric MALT lymphoma and early gastric cancer: is residual lymphoma a risk factor for the development of gastric carcinoma?, Ann Oncol, 16, 1232, 10.1093/annonc/mdi242 Zucca, 1995, High incidence of other neoplasms in patients with low-grade gastric MALT lymphoma, Ann Oncol, 6, 726, 10.1093/oxfordjournals.annonc.a059292 Au, 1999, Incidence of second neoplasms in patients with MALT lymphoma: no increase in risk above the background population, Ann Oncol, 10, 317, 10.1023/A:1008328226599 Warren, 1932, Multiple primary malignant tumors: a survey of the literature and a statistical study, Am J Cancer Res, 16, 1358 Wundisch, 2005, Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication, J Clin Oncol, 23, 8018, 10.1200/JCO.2005.02.3903 Nakamura, 2012, Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multi-centre cohort follow-up study of 420 patients in Japan, Gut, 61, 507, 10.1136/gutjnl-2011-300495 Marcelis, 2019, MALT lymphoma as a model of chronic inflammation-induced gastric tumor development, Curr Top Microbiol Immunol, 421, 77 Wündisch, 2005, Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication, J Clin Oncol, 23, 8018, 10.1200/JCO.2005.02.3903 Siakantaris, 2009, Early-stage gastric MALT lymphoma: is it a truly localized disease?, The oncologist, 14, 148, 10.1634/theoncologist.2008-0178 Hyeon, 2018, Targeted deep sequencing of gastric marginal zone lymphoma identified alterations of TRAF3 and TNFAIP3 that were mutually exclusive for MALT1 rearrangement., Mod Pathol, 31, 1418, 10.1038/s41379-018-0064-0 Harhaj, 2020, Lymphotropic viruses: chronic inflammation and induction of cancers, Biology, 9, 10.3390/biology9110390 Morgner, 2000, Helicobacter heilmannii-associated primary gastric low-grade MALT lymphoma: complete remission after curing the infection, Gastroenterology, 118, 821, 10.1016/S0016-5085(00)70167-3 Teresa, 2019, Helicobacter pylori and epstein-barr virus infection in gastric diseases: correlation with IL-10 and IL1RN polymorphism, J Oncol, 2019, 10.1155/2019/1785132 Sun, 2020, EBV-positive gastric cancer: current knowledge and future perspectives, Front Oncol, 10, 10.3389/fonc.2020.583463 Re, 2020, Overview of epstein-barr-virus-associated gastric cancer correlated with prognostic classification and development of therapeutic options, Int J Mol Sci., 21 Lim, 2009, Assessment of human papillomavirus and Epstein-barr virus in lung adenocarcinoma, Oncol Rep, 21, 971, 10.3892/or_00000310 Teixeira Mendes, 2017, Marginal zone lymphoma: associated autoimmunity and auto-immune disorders., Best Pract Res ClinHaematol, 30, 65, 10.1016/j.beha.2016.07.006 Yadlapati, 2016, Autoimmune/inflammatory arthritis associated lymphomas: who is at risk?, BioMed Res Int, 2016, 10.1155/2016/8631061 Skibola, 2014, Medical history, lifestyle, family history, and occupational risk factors for adult acute lymphocytic leukemia: the InterLymph Non-Hodgkin Lymphoma Subtypes Project, J Natl Cancer Inst, 2014, 125, 10.1093/jncimonographs/lgu009 Sriskandarajah, 2017, Epidemiology and environmental aspects of marginal zone lymphomas, Best Pract Res Clin Haematol, 30, 84, 10.1016/j.beha.2016.07.002 Zelenetz, 2014, Non-Hodgkin's lymphomas, version 4.2014, J Natl Compr Canc Netw, 12, 1282, 10.6004/jnccn.2014.0125 Zucca, 2013, Gastric marginal zone lymphoma of MALT type: ESMO clinical practice guidelines for diagnosis, treatment and follow-up, Ann Oncol, 24, vi144, 10.1093/annonc/mdt343 Evans, 2015, The role of endoscopy in the management of premalignant and malignant conditions of the stomach, Gastrointest Endosc, 82, 1, 10.1016/j.gie.2015.03.1967 Pich, 2019, The mutational footprints of cancer therapies, Nat Genet, 51, 1732, 10.1038/s41588-019-0525-5 Keegan, 2017, Second primary malignant neoplasms and survival in adolescent and young adult cancer survivors, JAMA Oncol, 3, 1554, 10.1001/jamaoncol.2017.0465 Paganetti, 2012, Assessment of the risk for developing a second malignancy from scattered and secondary radiation in radiation therapy, Health Phys, 103, 652, 10.1097/HP.0b013e318261113d Dasu, 2005, The use of risk estimation models for the induction of secondary cancers following radiotherapy, Acta oncol, 44, 339, 10.1080/02841860510029833 Brower, 2013, Tracking chemotherapy's effects on secondary cancers, J Natl Cancer Inst, 105, 1421, 10.1093/jnci/djt273 Turcotte, 2019, Chemotherapy and risk of subsequent malignant neoplasms in the childhood cancer survivor study cohort, J Clin Oncol, 37, 3310, 10.1200/JCO.19.00129 Treutwein, 2020, The influence of radiotherapy techniques on the plan quality and on the risk of secondary tumors in patients with pituitary adenoma, BMC cancer, 20, 88, 10.1186/s12885-020-6535-y Xiang, 2020, Second cancer risk after primary cancer treatment with three-dimensional conformal, intensity-modulated, or proton beam radiation therapy, Cancer, 126, 3560, 10.1002/cncr.32938 Zhang, 2020, Secondary cancer risk after radiation therapy for breast cancer with different radiotherapy techniques, Sci Rep, 10, 1220, 10.1038/s41598-020-58134-z Kuczynski, 2013, Drug rechallenge and treatment beyond progression–implications for drug resistance, Nat Rev Clin Oncol, 10, 571, 10.1038/nrclinonc.2013.158